Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The primary goal of this study is to characterize the pharmacokinetics of doxylamine
succinate in children ages 2 to < 18 years. Once characterized, these pediatric
pharmacokinetic data will be pooled with historical adult PK data from other studies to
assess whether the existing Over-the-Counter (OTC)doses provide comparable systemic drug
exposure as that associated with efficacy in adults.